Angela is the Chief Financial Officer for InCarda Therapeutics with over 25 years of financial and commercial leadership experience in the pharmaceutical/biotech industry in US, Europe and Asia.
Prior to joining InCarda, Angela was the Chief Financial Officer at MAIA Biotechnology, Inc. where she led finance operations, fundraising, investor relations, strategic financial planning, treasury, tax, and corporate business development. Before MAIA, Angela advised and worked closely with founders/entrepreneurs and private companies in growing their businesses, as well as a member of corporate management in major pharmaceutical and life science companies including Novartis, Sanofi, and Syngenta, where she built and led cross-function teams covering finance, legal, supply chain and site management, supporting operations generating over $1B in sales. Beyond Finance, she has held commercial leadership positions across various functions, heading up Business Unit Sales and Marketing, Business Development and Licensing, as well as Strategic Planning. She worked in a range of disease areas including oncology, infectious disease, and ophthalmology. Earlier in her career, she was with Deloitte and Arthur Andersen providing financial consulting and audit advisory services to both public and private companies.
Angela obtained her CPA license in both California and New Jersey and holds an EMBA degree from the Institute for Management Development (IMD) in Lausanne, Switzerland, a MABR degree from SBS Swiss Business School in Zurich, and a B.Sc. degree in Financial Accounting from Rutgers University in New Jersey. She speaks Mandarin, German and French. Angela lives in Danville with her family and enjoys traveling, hiking, languages and music. She is an active volunteer with Stepping Stones, a non-profit organization that teaches English to underprivileged children in China.